News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,559 Results
Type
Article (2453)
Company Profile (39)
Press Release (37067)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14242)
Career Advice (77)
Deals (2101)
Drug Delivery (9)
Drug Development (4533)
Employer Resources (10)
FDA (549)
Job Trends (849)
News (20878)
Policy (1164)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (148)
Allergies (6)
Alliances (3531)
ALS (4)
Alzheimer's disease (47)
Antibody-drug conjugate (ADC) (15)
Approvals (556)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (569)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (5)
Breast cancer (38)
Cancer (207)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (48)
Cervical cancer (3)
Clinical research (3597)
Collaboration (98)
Compensation (48)
COVID-19 (180)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (136)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (497)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (16)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4279)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6185)
Executive appointments (97)
FDA (609)
Featured Employer (3)
Funding (79)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (155)
Healthcare (751)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (11)
Interviews (7)
IPO (999)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (37)
Leadership (1)
Legal (215)
Liver cancer (6)
Lung cancer (31)
Lymphoma (10)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (319)
Medtech (319)
Mergers & acquisitions (1170)
Metabolic disorders (34)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (92)
NextGen: Class of 2025 (357)
Non-profit (165)
Northern California (381)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (12)
Pain (9)
Pancreatic cancer (4)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (4)
Peanut (1)
People (5682)
Pharmaceutical (5)
Phase I (1494)
Phase II (1707)
Phase III (1056)
Pipeline (75)
Policy (12)
Postmarket research (41)
Preclinical (599)
Press Release (2)
Prostate cancer (7)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (24)
Real estate (420)
Recruiting (5)
Regulatory (924)
Reports (6)
Research institute (147)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (362)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (490)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1824)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Last 7 days (52)
Last 30 days (215)
Last 365 days (2714)
2025 (779)
2024 (2780)
2023 (3011)
2022 (3908)
2021 (4215)
2020 (3609)
2019 (2137)
2018 (1637)
2017 (1894)
2016 (1697)
2015 (1889)
2014 (1397)
2013 (1209)
2012 (1406)
2011 (1351)
2010 (1193)
Location
Africa (43)
Alabama (1)
Arizona (15)
Asia (2036)
Australia (307)
California (859)
Canada (136)
China (43)
Colorado (21)
Connecticut (14)
Delaware (7)
Europe (4009)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (16)
India (1)
Indiana (33)
Japan (14)
Kansas (12)
Kentucky (2)
Maryland (25)
Massachusetts (304)
Michigan (8)
Minnesota (15)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (93)
New York (53)
North Carolina (99)
Northern California (381)
Ohio (26)
Oklahoma (2)
Oregon (4)
Pennsylvania (53)
Rhode Island (2)
South America (43)
South Carolina (1)
Southern California (362)
Tennessee (2)
Texas (73)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (56)
Wisconsin (7)
39,559 Results for "seer biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics
April 15, 2025
·
2 min read
Press Releases
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
February 24, 2025
·
1 min read
Press Releases
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
February 28, 2025
·
8 min read
Press Releases
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
February 20, 2025
·
4 min read
Press Releases
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
January 2, 2025
·
1 min read
Business
Seer Reports First Quarter 2024 Financial Results
Seer, Inc., a leading life sciences company commercializing a disruptive new platform for proteomics, reported financial results for the first quarter ended March 31, 2024.
May 8, 2024
·
7 min read
Biotech Bay
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
Seer, Inc. announced the launch of the Seer Technology Access Center in Bonn, Germany, providing the European biopharma and life sciences communities with service programs and the latest mass spectrometry technologies to optimize deep, unbiased proteomic studies.
May 8, 2024
·
4 min read
Biotech Bay
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
Seer, Inc. announced that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to date utilizing the Seer Proteograph™ Product Suite and Thermo Fisher Scientific’s Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer.
June 2, 2024
·
4 min read
Press Releases
Seer to Participate in Upcoming November 2024 Investor Conferences
November 11, 2024
·
1 min read
Press Releases
Seer Reports Third Quarter 2024 Financial Results
November 7, 2024
·
7 min read
1 of 3,956
Next
